Literature DB >> 33834325

Comment on "Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy".

Chandler S Cortina1, Amanda L Kong2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33834325     DOI： 10.1245/s10434-021-09931-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  The Potential Impact of AMAROS on the Management of the Axilla in Patients with Clinical T1-2N0 Breast Cancer Undergoing Primary Total Mastectomy.

Authors:  Martine Moossdorff; Faina Nakhlis; Jiani Hu; William T Barry; Katya Losk; Courtney Haskett; Marjolein L Smidt; Tari A King
Journal:  Ann Surg Oncol       Date:  2018-05-31       Impact factor: 5.344

2.  Delayed Adoption of Evidence-Based Breast Cancer Surgical Practices: History Repeats Itself.

Authors:  Sara H Javid; Benjamin O Anderson
Journal:  JAMA Oncol       Date:  2018-11-01       Impact factor: 31.777

3.  Surgeon Attitudes Toward the Omission of Axillary Dissection in Early Breast Cancer.

Authors:  Monica Morrow; Reshma Jagsi; M Chandler McLeod; Dean Shumway; Steven J Katz
Journal:  JAMA Oncol       Date:  2018-11-01       Impact factor: 31.777

4.  Reply to Comment on: "Women Could Avoid Axillary Lymph Node Dissection by Choosing Breast-Conserving Therapy Instead of Mastectomy".

Authors:  Armando E Giuliano; Marissa Vane
Journal:  Ann Surg Oncol       Date:  2021-04-23       Impact factor: 5.344
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.